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The biologic effects of the vitalTIin D horlTIone 1,25-
dihydroxyvitalTIin D , (1,25(OHhD,) are believed to 
be lTIediated by an intracellular vitalTIin D receptor, 
which after ligand binding acts as a transcription 
factor 1TI0duiating expression of a variety of genes. 
Besides having a well-known role in calciulTI lTIetab-
olislTI, this hormone is an ilTIportant regulator of 
proliferation in a lTIajority of norlTIal and neoplastic 
cells. Keratinocytes provide a convenient 1TI0dei for 
inv e s tigating the growth-related effects ofvitalTIin D 
in norlTIal cells. Growth of keratinocytes lTIay be 
e ither stilTIulated or inhibited by 1,25(OHhD" de-
pending on the degree of cell differentiation. We 
show here that 1,25(OH)zD3 stilTIulates DNA synthe-
R esearch has shown that 1,25-dihydroxyv itamin 0 3 (1, 25 (O H)2D , ) p lays an important ro le in the regulation of ce ll growth and di ffe rentiation (Walte rs, 1992) . In most ce ll- culture sys tems, in-cludmg keratm ocytes, "I ,25 (0 I-lh D, blocks prolif-
era tion and stimulates ce llul ar differentiation. T hese bi o logic re-
sponses have been primarily attributed to the activation of the 
nucl ea r vitamin ° receptor (VOR), which be longs to a superf.,mily 
of nuclea r steroid receptors together w ith re tino id A and X 
recepto rs and recepto rs fo r triiodothyronine. After binding o f the 
ligand, these recepto rs fo rm hOl11o- o r he te rodimers with o the r 
m embers of the supe rfamil y and ,lCt as transcripti on fac tors modu-
lating the ex press io n of a va,-iety o f genes (Ca rlberg et ai , 1993; 
Schrader e/ ai, 1994 ). T his is referred to as the "genomic" response 
because this pathw ay is dependent on gene transcrip tion and ne w 
protein syn thes is. 
R.ecen t evidence sugges ts that ste roid ho rmones, including 
1,25(O H )20 " may signal independentl y o f the genomic pathway . 
Stud ies show th at 1,25 (0 1-l),D, may activate pro tein kinase C 
(Merke et ai, 1989; Yada et ai, :1989 ; van Lee uwen et ai, 1992; Khare 
et ai, 1993, '1994; Bissonne tte ct ai , 1995; Slater ct !II, 1995) , 
modul ate phospho lipid metabo lism (M ore Lli et ai, 1993; de DO);lI1d 
et ai, 1994), stimul ate fo rm ation of cyclic nucl eotides (Barsony and 
Marx, 1988, 199 1; Uellido et III , 1993 ; Kll are et ai, 1993, 1994) , and 
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sis via sequential activation ofRaf and the lTIitogen-
activated protein kinase. Activation of these kinases 
is independent on protein and ITIRNA synthesis and is 
preceded by rapid tr,rosine phosphorylation of an 
adaptor protein p66s lC and forlTIation of a cOlTIplex 
between p66shc , a bridging 1TI0iecuie Grb2, and a Ras 
activator, ITISos . VitalTIin D receptor protein associ-
ates with Shc, indicating that this steroid horlTIone 
is able to signal through the transcription-indepen-
dent pathways silTIilar to those used by peptide hor-
nlones and cytokines. Ke}, lVol'ds: cell cycie/stel'oid 1101'-
lIIolleshlitamill D l'eceptOl'/sigllal tmllsdllctioll/tYl'osille killase. 
] lI1J1est De1'lllatol 106:1212-1217, 1996 
t,-igger calcium transpo rt (de Doland and N orman, 199 0a, 1990b ; 
J ones and Sharpe, 1994; Sergeev and R.ho ten, 1995) . T o describe 
these phenomena, N orman and Nem ere pro posed the term " l1on-
genomic response" to emphasize the independen ce of the classic 
transcripti on-dependent signaling o f ste roid ho rmones (Nem ere 
and Norm an. 1987; N orman et al. 1992). T he nongenomic m ech-
anism has been claimed to be responsible fo r transcaltachia (rapid 
intes tina l calciulll t ranspo rt) in mammals (Nemere and Norman , 
1987; de Doland and No rman , 1990a), but it has not been clear 
whe the r the nongenomic events play any ro le in th e regulation of 
ce ll prolife rati on and differentiation. 
Inv o lvem ent of nongenomic mechanisms has been pos tulated in 
the regul ation of g ro wth o fk eratinocytcs by ") ,25(OH),0 .,. Yada et 
al (1 989) and o ur o wn results (Gniadecki, 1994) documented a 
rapid stimulation o f prote in kinase C activi ty in epidermal ce lJ s by 
1,25(01-1)20 3 and its analog KI-I 1060. J ones and Sharpe (1 994) 
dem onstrated a rapid increase in intrace ll ular calcium concentration 
after ex pos ure to 1 ,2 5(0I-lh D, and a variety o f vitamin D analogs. 
but o th er iJ1Ves tigato rs were unable to tlnd evidence for either 
protein kinase C invo lvem ent (Koizumi et ai, 1991) o r stimulation 
of calcium currents (Pi ll ai et III , 1995 ). 
W e ha ve recently o bserved tha t the direc tion of the pro liferative 
response to 1. ,25(0 1-1 ), 0 3 ill cultured human ke ratin ocytes depends 
on the extrace llular calcium concentra tion and the degree of ceLl 
diWercntiation (Gniadecki , 1996). In ce lls active ly pro liferating in 
media containing low calcium concentrations, treatment wi th 
1 ,25 (01-l)2D l imposes a pro liferative block in G, phase o f the cycle. 
In contrast, in cells induced to differentiate by elevation of calcium 
concentration , 1,25(OH)20 , stimu lates rathe r than inhibits D NA 
synthesis. U sing thi s model, we in vestiga ted whe ther an y rapid 
nongenomic events are indu ced by 1 ,25(01-l) 2D , in ke ratinocyres. 
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Figure 1. Stimulation of DNA synthesis and activation of MAPK and Raf by l,25(OH),D.l' Normal human kcratinocytes were preincubated in 
medja con win in!,; 0. 15 mM CaCI2 (s,/ llan's ). 1.8 mM CaCI2 (cirrles) , o r I.S mM CaCI2 with th e following: actinomycin D (dia l/lo lld ... ). tyrp hostin (SIal'S), 
antisense rl1j"oli goJt1 crs (tr;ml,(!les). no n sense o ligOJ1u cleotides (JOWl'" semicircles), o r sense raj o ligon ucleotides (;' I/Ier(('(/ 1";(lI1g/('S). The calcium con cl! n tration was 
adjusted 27-30 h before addi tion of 1,25(0 1-1),0.,; 0. 1 /-lM tyrph ostin or 5 /-l!,;/ml actinomycin D w as added 2 h (ope/l -'}'lIIbols) or 24 h (closed -'}' lIIllO ls) before 
me additi o n of 1,25(01-1) , 0., . Cell s were prcincubated with antisense o r sense /'/!( o li!,;onl e rs 24 h before the additio n of 1.25(0 I-l ),DJ . a. synthesis of DNA 
(measure d as incorporatio n of UrdU) in kcratinocytes 24 hatter I!xposure to differl!nt con centrations of 1 .25(01-l) , D.l and tyrph ostin or actinomycin D o r 
laJ o Ugol11c rs. It-rl. Iysates from the ceUs tr""ted with 1,25 (O H ),D, (10 - " M) fo r indicated t imes were iJ11ll1lllloprecipi tate d w ith anti-MAI'K (b and r) o r 
anri-Raf (d) il lltibodies. and kin<l sc activity of the inullulloprccipitatc \vas 111casl1rcd using ll1yclin basic p ro te in 'IS a substrate . T h e cflcccs of tyrphostin and 
actinomycin D o n MAPI< are shown in b; ,. illu strates inhibition of MAPK activatio n by anti se nse raJ o li gom e rs. M ea n va lues (n = 3) with SD arc shown. 
Because activation of R.af k.inase mitogen-activated pro tein k.inases 
(MAPKs) is esscntial for stimula tion of growth in many types of 
cells (Pelicci CI "I, 1992 ; Blcnis, 1993; Egan cl nl, 1993; Laird el nl, 
1995), vve asked w hether R.af and MAPK arc activated by 
1,25(OH) 2D,. 
MATERJALS AND M ETH ODS 
Kcratinocyte Culture C ryopreserved no rmal human ke ratin ocytcs 
were purchased fro m C lo nl! ti cs (San Diego, CAl and cultured in keratino-
eyte basal med ium (Clo netics) containing 0. 15 mM CaCl2, 1 ng/ ml I recombinant hUlllan epide rmal !,;rowth ('tctor, 5 /-lg/1111 insulin. 0.5 /-l!,;/1111 
hydroco rti sone. 50 /-lg/ llll gentamicin . 50 ng/ml amphotericin 13, and 0. 1 % 
~vine pituitary extract. C ultures were ma intained at 37°C in a humidified 
atmosph ere of SIX. CO2, Ce ll s were passaged at 80 - 9{)!XJ conflu e ll ce after 
trypsinization with 0.2 ml /cl1l2 0.05')1, trypsin w ith 0.02'10, ethyle nediam ine 
tetraace ti c acid solution . and were seeded at a density of 2500 cells/cm ' . 
Second- an d third-p;lssagc cells '''ere lI sed fo r the studi es. For bro l1l odc-
oxyuridinc (UrdU) labeling. cell s were transferred to the l1I edium without 
epiderm a l gl'Owth f.,cto r and antibiotics for 48 h . The ca lcium concentrati o n 
was adj u sted 27- 30 h before the addition o f 1.2S(O H),D, . T),rphostin (final 
concentration 0. 1 /-lM; Life Tcclm o logies, Gaithersburg. MD) or actinom y-
cin D (5 l.Lg/ml ; Sigma , St. Lo uis. M O) was added 2 h or 24 h befo re the 
addition of 1.25(OI-l),D,. Antisense rnJoli gomers of th e seq uence described 
by Ried e l e l al (1993) were used to downregulatc Raf pro tein expressio n, 
and nonsense ~l11d se nse o ligolllcrs were used as contro ls. In the preliminary 
experimcnts, a ma ximal downregulation of R af protein (by approximately I 90%, as assessed by Western blo tting) was obt:l ined with 30 /-lM antise nse 
raJoUgonuc!eotides aftcr 24 h of incubatio n with the cells. These conditio ns 
were used .in the present stud y. BrdU labe (jn!,; was pe rto rIlled with t.he Cell 
I Proliferation IGt (Amersham International). Four ho urs before termination 
I of an experim c nt. BrdU at a final dilution I :500 was added to the wells . CeUs werc w"shed I!xtensively with phosphatc-bufl'ered saline , fixed in a 
mixtu_ce of 90o/r, ethan o l w ith 5 '10 acetic :lcid. and blocked with S'X, bovine 
.erum a lbumin (fraction V) in phosphate-bufl'ere d salin e supplemented w ith 
0.1 % Tween 20 . BrdU- pos itivc nuclei wl!re labeled with th e anti-BrdU 
ancibod y and detected with th e perox idase-labeled second antibody by 
I enzY'.ne-linked iIllmullosorbent assay, according to the procedure described by the producer. Control ex pe rim e nts showed ne!,;ative enzym e-linked 
immunosorbcnt assay reactions in smnplcs incubated with the second 
antibody o nly. 
Immunoprccipitatioll For im111111l0prccipitatioll iu denatured condi-
DOns, the cells were dissolved in bo iling 10 IIIM Tris H C I, pl-l 7.4 , with 1% 
sodiu m d odecyl su lf.,te. To ana lyze the prote in-protein interactions. we 
wed the n ative inlll1unoprccipitatio n te chnique. w hereby the cells were 
lysed for 1 h at 4°C in th e lys is buffer (10 111M Tris H C I. pH 7.4. 1% T,;ton 
X100, O.5'Yo N o nidet 1'-40, 150 mM NaCl, 20 mM NaF, 0.2 mM N a, VO." 
I mM eth y l e n ediamine tetra ace ti c acid , 1 mM cth ylcn e!,;lycol-bis{/3-al11ino-
I!thyl cth er)-IV.N.N' .N' -tetraacl! tic acid. 0.2 mM phc nylmethylsu lfonyl 
fluoride. 50 /-lg/ mllc upep tin, 50 /-l!,;/ 1ll1 aproti nin , and 20 /-lg/ ml pcpstatin). 
Al iquots contain ing 0.4 mg (denatured) and 1 111!,; (native) of protein were 
preclea rcd w ith 20 /-ll or 50% slurry of protein A-Sl!p harose in the I)'sis 
bull'er for 30 min at 4°C and iml11unoprecipitated with 3 /-lg of the 
appropriate antibody for 24 h and tl 1I! saml! amount of the secondary 
an tibody forI It at 4°C. Comple xes were adsorbed to protein A-Sepharose 
given ill th e above quan tity. washed thre e rinlC$ w ith the lysis buff~r , and 
<lllal yzcd with western b lo ttin g (LacIl1111Ii ! 1970) using e llhall ced c h c l1lill.l-
minescl!nt dctectio n (A m e rsh,nn Inte rnationa l, Little C halfo nt., U.K.) . To 
Ininirnize the possibility of n o nspecifiC il11111ullop rccipi rCl ti o n, we reversed 
rhe seq uence of add ition of antibodies in sonI C experimen ts. and assessed the 
purity or tl1I! i11l11lunoprec ipitatcs in a Coomassie blue-stainl!d gel. In the 
latte r instance. o nl y two protein bands o ri gina ting fro lll denatured in1Tllll-
ll og1obulitl heav y and ligh t cha ins were lIsu a ll y see n . T he concentration of 
specifica ll y precipitated proteins was too low fo r visualization with th is 
method. 
The fo llowing antibodies were used: anti-ph osph or),rosine (clone PY20) , 
anti-She , :l nti-G rb2, ill1ti-1l1S0S (n il 1l1 urin c 111onocional an tibo di es: Trans-
du cti o n Laboratories. Lex ington, f{ V) ; an d anti-VDR rat m o noclona l 
(clone 9A7-y: C hemicon , Tem ecula . CAl . Seconda.ry antibodies , rabbit 
altti-mouse , and rabbit "nti-rat we re ob tained fro m Dako (G lostrup , 
Denmark). For detl!ctio n in westertl blotting, approp riate horserad ish 
peroxidasl!-Iabeled sl!cond anrjbodies we re used (Dako). 
Kinase Assays Ce lls were 1)'sed in the lysis burrel' for 60 min at 4°C . 
Aliq uots of superna ta nt containing 100 ILg of proteil1 were iInnlUtlOprecipi-
rated ill n ative couditio ns with 3 J..lg of ITl o noclonal <1Ilti-MAPK a ntibody 
recogniz ing both EIU<. I and ER..K2 (Zymcd. San Francisco. CA) o r 
po lyclonal goat anti-Ra f antibody (AfEniti, Nottingham. UK) for 1 h, an d 
fo r an addition al 30 min w ith 3 /J-g of rabbit anti-mouse and rabbit allti-goat 
immunoglobulins. respective I)' (both fron) Dako) . The iml1lune complexes 
were co llected on protein A-Seph arosc (Pha rmacia. Uppsala , Sweden). 
washed three tiInes in the lysis buffer ;lIld three times with the kina se buffer 
(10 mM Tris H C!. pH 7.2 , 150 111M NaCI , 10 mM MgCI2' 0.5 111M 
dithiothre itol. 0.2 mM phenylmethylsulfoll yl flu o rid e, 50 /-lg/ ml Ic upeptin . 
50 /-lg/ ml ap rotinin. and 20 /-lg / ml pe pstatin). and incubated at 3rC for 15 
min with 40 /-ll of th e kina se bufFe r co nta inin g 25 /-lM aden osine tr iphos-
phate (ATP) , 2.5 /-lCi of [J ' P-y'iATP (Alllershalll In ternation al) . and I 
lllg / 1111 m yelin basic protein. which is a substratl! fo r both MAPK and Raf 
(Force CI al. 1994) . Phospho r),lated produc t se parated fi'om the fi'ee iso tope 
o n phosphocellulose filters (Pierce, rlockford. IL) was COUll ted in a 
sc iut illrl tioll counter. 
R.ESULTS 
Activation of MAPK and Raf by 1,25(OH), D 3 In keratino-
cytes grown in 0.15 mM ca lciul11.I ,25(O HhD, imposed a prolif-
e rativ e block. but in cells pretreated in media containing 1.S 111M 
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calcium, g rowth stimu la tio n was observed after exposure to 
1,25(OH)20] in low concentrations (10 - " to 10 - ') M) (Fig 1a). 
To investigate w hether MAPK is activated by 1,25(OH)~O], we 
immunoprecipitated MAPK ["0111 cell Iysates and assayed immuno-
complexes for kinase activity in the presence of myelin basic protein 
as a substrate (Fig lb,c) . In conAuent cultures preincubated w ith 
1.8 mM CaCI2, but not in those cu ltured w ith 0.15 mM CaCI" 
1,25(OHhD] rap idl y stimul ated MAPK activ ity. -
MAPK is phosphorylated by MAPK kinase MEK, w hich in turn 
is activated by Raf kinase (Egan el aI, 1993) . To see whether 
1,25(OH)20J stimulates R.afkinase, we performed a similar immu-
nocomplex kinase assay using polyclonal anti-R.af antibodies. As 
shown in Fig 1d, Raf kinase activity was stimu lated after approx-
imate ly 5 min of exposure to 1,25(OHhD] . Activation of MA PK 
and Raf preceded the increase of DNA synthesis, suggestin g a 
ca usal relationship between these processes . To address this possi-
biJjty, expression of Raf protein was inhibi ted by antisense o ligo-
nucleotides (Fig la,c). Selective knockout ofRaf reduced both the 
induction of MAPK activity and DNA synthesis, indicati ng that the 
Raf-MAPK pathway was directly involved in the stimulation of 
keratinocyte pro li feration by 1,25(OH)2D]. To in vestigate whether 
vitamin 0 stimulates MAPK through a transcription-dependent 
m echanism, we incubated kerati nocytes with 1.25(OH), D in the 
presen ce of RNA and protein synthesis inhibito rs (actin~m~cin D, 
Fig 1; and cycloheximide, not shown) and tested cell Iysates for 
MAPK activ ity. T hese inhjbitors did not prevent the activation of 
~APK. Thus, activatio n of MAPK by 1,25(O H )2D3 did no t 
lIlvolve the known VDR-medIated mechanisms that arc dependent 
on transcrip tion and protein synthes is. 
1,25(OHhD] Induces Phosphorylation of Shc and Interac-
tion Between Shc a nd Grb2 Activation of the £laf-MAPK axis 
takes p lace w hen a receptor protein becomes phosphorylated on a 
tyros ine residue, or when an occupied receptor in teracts with a 
nonrec.eptor tyrosine kinase that phosphorylates Shc proteins 
(Pe.hcct ef al ,. 1?92; Ega~l ef aI, 1993; Taniguchi, 1995). Phosphoty-
roslIle- conta1ll111 g protems bmd to the proteins G rb2 and m Sos the 
la ttet· of which sti l~lul ;l tes guanosine triphosphate loading onto'Ras 
and furth e r actlvatton of Raf. We the refore asked w hethe r a similar 
sequen ce of events occurs il? kcratinocytes afte r appljcation of the 
Vtta111 111 D hormone. ActtvatlOn of MAPK was clearl y dependent on 
tl~e tyros in e kinase ac tivity, as tyros ine kinase inhibito rs (tyrphostin, 
Fig 1; and genrstell1 , not shown) blocked MAPK activation in 
response to 1,25(OH)2DJ. 
.To evalu ate t he ro le of Shc in ~i tarnil1 D sign aling, we deter-
nnned whethe r Shc becom es tyros ll1e phosphorylated afte r expo-
sure of the cells to 1,25(OH) 2D3 (Fig 2). Phosphotyrosine-contain-
ing proteins were immlll1~precipi tated with a m onoclona l antibody, 
separated by polyac rylamIde gel e lectrophoresis, and immunoblot-
ted with anti-Shc antibody . To exclude nonspecific resul ts, con tro l 
experiments were done w ith the reverse order of added an tibodies: 
Ce ll Iysates were precipitated with an ti-Shc an tibody and bl otted 
with anti-phosph otyrosine antibody. T he resul ts showed tha t 
1,25(OH)2D] provoked tyrosin e phosphorylation of p66s h C• and to 
a lower extent p52sl",. Phosphorylation of p66s h c was detected in 
both calcium-pretreated and non pretreated ce lls. 
Next we stlldied whether Shc fo rms complexes with Grb2 and 
mSos. Lysates fi·om cells treated with 1 O -~ M 1.25(OHh03 were 
immunoprecipi tated in native condi tions with anti-Sh e an tiserum 
and immun o bl otted with anti-Grb2 antibody, and "ice IIersa (Fig 
3a,I,) . Grb2 was found to associate w ith Shc selectively in the 
Iysates fi·om calcium-pre treated ce ll s. Furthe r, m Sos was present in 
these complexes, as p66s h c could be detected in I11S0S precipitates 
['·0111 Iysates ofkera tinocytes preincubated with 1.8 111M CaCI, and 
stim ula ted for 3 o r 5 min with 1 ,25 (OH)2D J (Fig 3c). Surpri si; lgly, 
an assoc iation between mSos and Grb2 was also indu ced by 
1,25(OHhD3 in cell s pre treated in high-calcium media (F ig 3d) . 
Association of VDR and Shc Upon Treatment With 
l,25(OHhD3 To determine whether VDR associates with Shc, 
we immunoprec ipitated cell Iysates with anti-Shc and anti-VDR 
Precipitation 
Ca"(mM) 
Time (min.) 
52 kDa -
46 kDa-
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blot 
anti -She anti -PY 
F igure 2 . Tyrosine phosphorylation of Sh e in response to 
1,25(OH),DJ • Kerotinocyrcs were prci llcubatcd for 27-30 hin media with 
0.15 mM or 1.8 111M CaCI2 and exposed to .10- 9 M 1.25(O H)2DJ for 
indicated timcs. Ce ll Iysnrcs were irnlllunoprecipitatcd in denatured condi-
tions with anti-phosphotyros inc antibodies (lnlles 1--1) or anti-Shc antibod-
ies (lfil/ es 5-8) and probed with anti -She or anti-phosphotyros inc antibodies. 
respectively. Positions of p66sh< and immunoglobulin heavy chain (lgGH ) 
arc indicated. A fai nter line below p66sl« reprcsents p52sl": p46s,,< could 
not be visuali zed because ofa positional overl ap with IgG,.,. T he experiment 
'was repeated three rin1cs w-ith identi cal resu lts . 
antibodies and probed with anri-V OR and anti-S hc antibodies. 
respectively (Fig 4). T hese experiments showed that VOR prorein 
co-precipitates w ith Shc in ce ll s stimulated w ith 1 ,25 (OHhD3· 
D ISCUSS ION 
T he data presented here suggest that 1,25(OH)20, triggers a 
signaling cascade , invo lving sequentially (i) the interaction ofVDR 
with Shc; (ii) tyrosine phosphorylation o f Shc and complex fo rma-
tion between Shc, Grb2, and mSos; (ij i) activation of Raf kinase; 
and (iv) activation of MAPK. T his novel siglJaling pathway is 
illustrated schcm atica lly in F ig 5. T he efFects of 1 ,25(OH)zD] may 
be class ifi ed as nongenomic, as mRNA and protein synthesis 
inhibitors did not abrogate thc activatio n of MA PK. In addition , the 
st.imulation of Raf and MAPK was rapid , w hich v irtua lly rules our 
the possibility that 1,25(OHhDJ indu ces the synthesis of an 
autocrine growth f.1cto r w hich then activates MAPK by binding to 
and activating cell-sttrface receptors. 
The activation of MAPK was clearly dependent on and preceded 
by an activation of Raf. I.n accordance w ith the present results, 
Lissoos et nl (1993) reported that 1,25 (OH) , D , stimulates Raf 
activ ity in hepatic [to ce lls and proposed that tI~is mechanism is 
responsible fo r induction of pro liferation in thjs cell type. Our 
experim ents with antisense rt!/"oligomers confirm the conclusions of 
Lissoos el al by sh owing that a knockout of R af protein diminishes 
MAPK activation and red uces con side rably the pro li fe rative re-
sponse of kcratinocytes to 1,25(OH)20 3. We were unable, how-
ever, to bl ock the proliferative response and MAPK activation 
com pletely in thi s ex periment. T he existence of alte rna tive path-
way(s) stim ulating MAPK, such as the recen tly described MAPKK 
cascade (C hao et aI , 1994; Van et (/1, 1994) or a residual Raf activity, 
could accoun t fo r th is fact. 
T he MAPK pathway is usually initiated by the phosphorylation of 
Shc proteins and their association w ith Grb2 and mSos, leading to 
the activation of £las. T he same seq uence of events was demon-
strated here in keratinocytes exposed to 1 ,25(OHh03' suggesting a 
functional re lationship between Shc phosphorylation and the for-
mation of a protein comp lex composed of Shc, G rb2, and ruSos. 
Unexpcctedly, p66s h c seems to be mainly in volved , w hich contrasts 
with the prcferential in volvement of p46 s h c ,uld p52shc during 
activation of growth facto r o r cytokine receptors. 
In many kinds of cells, the Grb2-mSos co mplexes preexist, and 
only the assoc iation between Shc and G rb2 is trigge red by exrra-
cellul ar stimuli. We were unable to dctect native Grb2-mSo 
complexes in ker,ltinocytcs, but their formation was initiated by 
treatm ent w ith 1.25(OH)2D3. T his resu lt is not necessarily i;l 
confii ct with the preexistence of Grb2-m Sos complexes in kerati-
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I Figure 3. Formation of complexes b etween Sh e, Grb2, and I11S0S in 
response to 1,25(OH)2D j . Kernrinocy tes were pr~in c ubated for 27-=~O h 
in media with 0.15 mM or I .S mM CaCI, and stnllulated With 10M 
1,25(OH)20 , fo r indicated times. Cell s were lysed and immuno.precipitated 
in native condi tions with ami-Shc (a) , anti-Grb2 (b). and antl-Sos (c and iI) 
antibod ies ; western blo tted; and probed with anti-Grb 2 (a and tI) and 
I ano-Sh e (1J and r) antibod ies. In c. a band berween p(,6Sh" and immuno-
I globulin heavy chain (lgG \-I) represents p52""·. T he experiment was repeated twice with identica l results. 
I 
I nocytes, b u t ma y simply ind icate th;lt co mplexes of Grb2 and mSos 
are too , ,,,eak to rem ain in tact during immunoprecipitatio n . A larger 
compl ex of Sh e . G rb2, and m Sos could be more stable. e nabling its 
precipitation in the n ative conditio n s. 
Afte r ex posure to ·1,25(OHhD3 • a compl ex form ed between 
VOR a nd Shc. T his was an unexpected fi n ding b eca use binding [0 
Shc i11vol ves Src h omology 2 domains (S H 2) or phosphotyrosin e-
I bindi.ng domains (Pe licci el (//: 1992 ; I~avanaugh cl (/ /, 19?5). YDI~ lacks SH2 and phosphotyrosme-bllldLllg domall1s. and It IS like ly I that ano ther protein is inv o lved in bridg ing ofYD R to Sh c (Fig 5) . 
We are now in the process of identifyin g oth e r protein compo n ents 
of the VDR-Sh c complex . 
A fuJly fu nc tional signaling casca de lead in g to the activatio n of 
MAPK a nd stimu lation of DNA synthes is was triggered by 
1,25(OH)2D3 o lll y in the kerati n ocytes preinc ubated in m edia 
containing an e le vate d calcium con centration . In the cell s c ultured 
in a low-c alcium e n v iro nm ent, 1 ,25 (OH)2D, did not stimulate cell 
growth alld MAPK was not signi fica ntl y activated; however , the 
initial step s of th e pu tative MAl)K cascade . i. e .. fo rm atio n of th e 
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Figure 4. Formation of a complex between Sh c and VDR ill 
response to 1,25(OH)2D,. I(cratinocytcs were prcincubatcd for 27- 30 h 
in lII edia with 0.1 5 111M or 1.8 111M CaCI, and still1ulated with 10- ') M 
1.25(0 1-1) , 0 , for indicated times. Cell s were lysed and immunoprecipi tated 
in native condirions with anti-VDR. antibody (a) or anti-Shc antibody (b). 
western blotted. and probed with anti-Shc (a) and anti-VOR. (1)). In a. a 
hand between p6c,SI,,' and immunoglobulin heavy cha in (lgG 'I) represents 
p52S\'". T he experilllent was repeated three tillles with identical resu lts. 
YDR-Shc compl ex and Sh c phospho rylation. took p lace in the 
latte r instan ce. T he cascad e was in terrupted downstream of t he Sh c 
p h osph o rylatio n step, precluding fo rmation of Sh c-Grb2 comp lexes 
in ce ll s c ul tured in low- calciunl m edia (Fig 5). The n ature of thi s 
inhibi t io n remai n s un known . but it is con ceivab le that an additional 
regulatory prote in binding to Shc o r Grb2 is invo lved. A lterna-
C§> 
low calcium ~ 
®DR 1,25(OH)2D3 ? -- VDR-She 1 
GENOMIC EFFECTS 
high calcium 
... 
activation of Raf 
1 
activation of MAPK 
Figure 5. Proposed nongenomie signaling pathway for 
1,25(OH),DJ itl keratinoeytes. After binding of 1.25(0 1-1 ), 0 , (blark 
tr;(",.~ft,). VOR. associa res with She. ca using ryrosin e phosphoryla tion (blac/..' 
s1"ares) of th" latter protein . It is li ke ly that an additional unidentified 
protcinll1ediates binding ofVOR. t.o Shc (1"e.<t;"" ",ark). In the ce ll s exposed 
prev io usly to 1l1cdia containing high ca1ciulll . phosphory lated She in teracts 
with the prowins Grb2 and mSO$, causing activation of"l"l..afkinase. probably 
via activation of I~as . Rat" kinase activates MAI'K ancl eventuall y ce ll 
pro life ration. In cell s culwred with low concentrations of calciulll. phos-
phorylated She docs not inter;)ct with Grb2 ;)nd II1Sos. ;)nd thus the signa ling 
cascade is illCerrupt.ed and activation ofMA I'K cloes nOl" take place. T he role 
of the p"t;)tive VOR-Shc-Grb2-mSOS com pie" in the act. ivation ofRafhas 
nut been shown direc tl y (lIa.< //('III; II ("). 
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tively, a protein inhibiting binding of phosphorylated Shc to Grb2 
may bc present in thc cells grown in low-calci um conditioll s. 
Taken together, our data suggest that 1,25(OH)2D 3 regulates th e 
growth ofkeratinocytcs by activa ting MAPK. Ncvcrthclcss, impo r-
tant pieces of evidence supporting thc cxistence of a VOR-Shc-
G rb2/mSos-Raf-MAPK cascade are lacking. T he functional signif-
ican ce of observed prote in complexes remains to be shown. T he 
molecular nature of the in terac tion between vOR and Shc is 
obscure, and there is no conclu sive evidcnce that VOR. is dit·cctl y 
responsible for phosphorylation of Shc. Stimulati on of MAPK has 
1I 0t been observcd for 1,25(OH) z0 3 or other stero id hormones, 
although events dependent on tyros inc phosphorylation havc been 
described for progesterone (Mendoza ci til, 1995) . It appca rs that 
the MAPK pathway involves vDR, previously believed to be a 
transcription fa ctor only. vOR may thus play a role in the 
nongenom ic eB:ec ts of 1,25(OH)z0 3' resembling the behavior of 
membrane growth factor reccptors. In this context, it is interesting 
to note that vDR is phosphorylated ill lIillo (Darwish e/ til, 1993; 
Jurutka ci ai, 1993) and binds to the cytoskeleton upon exposure to 
the ligand (Barsony e/ til, 1990; Barsony and Marx , 1990), events 
that arc also common to peptide hormone/growth factor receptors 
(Gronowski and Bertics, 1.995). It is tempting to speculate that the 
cytoskeleton provides a site for inte raction between l ,25(OH)zD 3 
and MAPK, as both proteins have been found to bind to microtu-
bLLles (Barsony e/ til , 1990; R eszka e/ til , 1995). T he genomic 
responscs elicited by steroid hormone receptors arc modulated by 
and partially dependent on MAPK. Kato cl ti l (1995) showed 
recently that the estrogen receptor is activated by phosphorylati on 
of MAPK on a serine residue. Because VOR is also phosphorylated 
on a serine moi ety ill lIillo Ourutka d til, 1993), there is an intriguing 
poss ibility that the described MAPK activa tion may constitute an 
amplifi cation mechanism for the genomic action of the vitamin D 
hormone. 
R esearch shows that 1,25(OHhD3 activates multiple signa ling 
pathwa ys linked to protein kinase C, G prote ins, or calcium 
channe ls. The MAPK cascade described here is therefore like ly to 
represent only one of m any pathways by which this hormone 
regulates ceU· growth. R ecent e vidence for the role of MAPK 
cascades in in tegrating distinct upstream signals (Schlaepfer eI til, 
1994; Maeda c/ til, j 995) may help to elu cidate the complex and 
he terogeneous non genomic events triggered in the cells by 
1,25 (OH)zO J. 
Mrs. Hel/e Flngll is ncklloll'/etlged Jar II"r e.-.:eel/elll leellllien/ Il tip. 
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